1 Silverberg MJ,Abrams DI.AIDS-defining and ono-AIDS-defining malignancies:cancer occurrence in the antiretroviral therapy era[J].Curr Opin Oncol,2007,19(5):446-451.

2 孙琦，陈辉树.恶性淋巴瘤的病因学研究进展[J].国际输血及血液杂志，2006,29(5):398-402.

3 裴强，韩潇，张炎，等.艾滋病合并淋巴瘤10例临床分析[J].中国实验血液学杂志，2018,26(1):146-152.

4 徐航娣，周韧.AIDS伴发的淋巴瘤的研究进展[J].国际病理科学与临床杂志，2006,26(3):220-224.

5 CDC.Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome[J].MMWR,1987,36(1):3s-5s.

6 Riedel DJ,Rositch AF,Redfield RR,et al.HIV-ussociated lymphoma sub-typo distribution,immunophenotypes and survival in anurban clinic population Leuk [J]Lymphoma,2016,57(2):306-312.

7 孙开宇，桂希恩，邓迪，等.53例艾滋病相关非霍奇金淋巴瘤患者的临床特征及预后分析[J].中华血液学杂志，2017,38(2):97-101.

8 Powles T,Metthews G,Bower M.AIDS related sysmteic ono-Hodgking’s lymphomas[J].Sex Transm Infect,2000,76(5):335-341.

9 Krause J.AIDS-related ono-Hodgking’s lymphomas[J].Microsc Res Tech,2005,68(3/4):168-175.

10 刘爱梅.230例艾滋病合并丙型肝炎检测结果的分析[J].广西医学，2008,11(11):1750-1750.

11 Wang YH,Fan L,Wang L,et al.Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy[J].Supportive Care in Cancer,2013,21(5):1265-1271.

12 Wang F,Xu RH,Han B ,et al.High incidence of hepatitis B virus reactivation in B-cell snbtype non-Hodgkin lymphoma compared with other cancers[J].Cancer,2010,109(7):1360-1364.

13 Dalia S,Chavez J,Castillo JJ,et al.Hepatitis B infection increases the risk of non-Hodgkin lymphoma:a meta-anaiysis of observational studies[J].Leukemia Research,2013,37(9):1107-1115.